Back to search results

Research Associate/Fellow

University of Nottingham - Cancer & Stem Cells

Location: Nottingham
Salary: £27,511 to £40,322 per annum, (pro rata if applicable) depending on skills and experience (minimum £30942 with relevant PhD). Salary progression beyond this scale is subject to performance
Hours: Full Time
Contract Type: Fixed-Term/Contract
Placed On: 6th September 2021
Closes: 5th October 2021
Job Ref: MED284521

The purpose of the role will be to have specific responsibility for research, developing research objectives and proposals for a research project in the tumour immunology group in the Biodiscovery Institute. You will be expected to manage, plan and conduct work using approaches or methodologies and techniques appropriate to the type of research, and will be responsible for writing up work for reports and publications.

You will resolve problems in meeting research objectives and deadlines in collaboration with others, identify opportunities and assist in writing bids for research grant applications. Prepare proposals and applications to both external and/or internal bodies for funding, contractual or accreditation purposes. You will collaborate with academic colleagues on areas of shared interest for example, course development, collaborative or joint research projects.

You are expected to make a contribution to teaching that is in balance with wider contributions to research and other activities: supervising undergraduate and/or postgraduate students projects as appropriate, participation in assessment of student knowledge and to co-supervise projects at Masters level.

You will join an established team led by Professor Lindy Durrant whose main areas of research interest include development of therapeutic antibodies and vaccines to cancer. 

The research will focus on the identification of immune responses to tumour antigens in in vivo models and also in long term cancer survivors. This will involve long term stimulations, T cell cloning, TCR identification and viral transduction of primary immune cells for validation of targets. The in vivo assays will help in validating the utility of identified tumour antigens in immune stimulation and therapeutic models.

You will have the opportunity to use your initiative and creativity to identify areas for research, develop research methods and extend your research portfolio.

This is a full time, fixed term position until 05 April 2023. The post is open to part time working, minimum 18h per week. Job share arrangements may be considered. 

Informal enquiries may be addressed to ian.spendlove@nottingham.ac.uk. Please note that applications sent directly to this email address will not be accepted.

Our University has always been a supportive, inclusive, caring and positive community. We warmly welcome those of different cultures, ethnicities and beliefs – indeed this very diversity is vital to our success, it is fundamental to our values and enriches life on campus. We welcome applications from UK, Europe and from across the globe. For more information on the support we offer our international colleagues, see our Moving to Nottingham pages.

For successful international applicants, we provide financial support for your visa and the immigration health surcharge, plus an interest-free loan to help cover the cost of immigration-related expenses for any dependants accompanying you to the UK. For more information please see the our webpage on Financial support for visas and the immigration health surcharge.

We value your feedback on the quality of our adverts. If you have a comment to make about the overall quality of this advert, or its categorisation then please send us your feedback
Advert information

Type / Role:

Subject Area(s):

Location(s):

Job tools
 
 
 
More jobs from University of Nottingham

Show all jobs for this employer …

More jobs like this
Join in and follow us

Browser Upgrade Recommended

jobs.ac.uk has been optimised for the latest browsers.

For the best user experience, we recommend viewing jobs.ac.uk on one of the following:

Google Chrome Firefox Microsoft Edge